Post-Pandemic Planning: What Will Change in Early-Phase Drug Development?

06/30/2020

Online

June 30th, 2020, 11am EDT

Even as governments around the world begin to re-open, COVID-19 will have a lasting impact on how the pharmaceutical industry functions both in the immediate future and long-term. The development, trial and manufacture of medications will drastically change as sponsors find new ways to interact with both contract manufacturing organizations and patients. How can you navigate this unprecedented environment while still meeting milestones? Join Thermo Fisher Scientific’s drug development and manufacturing experts for a unique, extended Q&A session and learn how to start navigating the new normal.

Key Learning Objectives:

The impact of COVID-19 on sponsor/CDMO relationships moving forward
How Thermo Fisher Scientific has maintained normal CDMO operations and plans to shift to meet new needs
Answers to your questions surrounding the new post-pandemic landscape

This is a webinar series, part 2 in this series will cover Post-Pandemic Planning: What Will Change in the Clinical Supply Chain?
Click here for details